Free hemoglobin determination at patients' bedside to evaluate hemolysis
Background: The authors report the relevance of using a point of care test (Helge®) for free hemoglobin determination and concordance of the values the with Cobas® 8000 and spectrophotometer methods. Results: The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. Conclusion: Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 2023 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Bioanalysis - 16(2023), 2 vom: 05. Jan., Seite 65-74 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Baud, Bastien [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Accuracy |
|---|
| Anmerkungen: |
Date Completed 22.12.2023 Date Revised 22.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/bio-2023-0116 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365413178 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365413178 | ||
| 003 | DE-627 | ||
| 005 | 20231227140001.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/bio-2023-0116 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1235.xml |
| 035 | |a (DE-627)NLM365413178 | ||
| 035 | |a (NLM)38050368 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Baud, Bastien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Free hemoglobin determination at patients' bedside to evaluate hemolysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2023 | ||
| 500 | |a Date Revised 22.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Background: The authors report the relevance of using a point of care test (Helge®) for free hemoglobin determination and concordance of the values the with Cobas® 8000 and spectrophotometer methods. Results: The within-run of the point of care test was <3%. Good correlations among the three methods were observed and an acceptable concordance for hemolysis index values from 50 mg/dl. An excellent agreement between the Cobas 8000 and the spectrophotometer was found. Conclusion: Automated methods represent methods of choice for free hemoglobin determination. An advantage of the Helge system is that it can be applied to samples experiencing a delay in evaluation due to the long distance between the collection site and the central laboratory. Another advantage is its use at the bedside, in the monitoring of extracorporeal membrane oxygenation patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ECMO | |
| 650 | 4 | |a POC | |
| 650 | 4 | |a accuracy | |
| 650 | 4 | |a bedside | |
| 650 | 4 | |a extracorporeal membrane oxygenation | |
| 650 | 4 | |a free hemoglobin | |
| 650 | 4 | |a interference | |
| 650 | 4 | |a point of care | |
| 650 | 7 | |a Hemoglobins |2 NLM | |
| 700 | 1 | |a Dupuy, Anne Marie |e verfasserin |4 aut | |
| 700 | 1 | |a Zozor, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Badiou, Stéphanie |e verfasserin |4 aut | |
| 700 | 1 | |a Bargnoux, Anne Sophie |e verfasserin |4 aut | |
| 700 | 1 | |a Mathieu, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Cristol, Jean Paul |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioanalysis |d 2009 |g 16(2023), 2 vom: 05. Jan., Seite 65-74 |w (DE-627)NLM196969840 |x 1757-6199 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:2 |g day:05 |g month:01 |g pages:65-74 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/bio-2023-0116 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 2 |b 05 |c 01 |h 65-74 | ||